Regular updates related to sourcing and the management of health products are available on this page. You can receive a notification every time a new update is published by using our really simple syndication (RSS) feed. See our RSS Feeds page for more information.
As part of a World Health Organization-led consortium to rapidly and equitably support access to COVID-19 health products and diagnostics, the Global Fund has developed the Accelerated Order Mechanism to support countries in the purchase of COVID-19 diagnostics. As lead procurer of automated COVID-19 diagnostics from Cepheid and Abbott, all eligible countries will be able to access these through the Global Fund.Read more
The Global Fund is working closely with key partners, international organizations, governments and technical agencies through a World Health Organization-led consortium to rapidly and equitably support access to COVID-19 health products and diagnostics for low- and middle-income countries.Read more
The Global Fund continues to work closely with our technical partners, especially the Stop TB Partnership's Global Drug Facility and our procurement service agents, as the global response to the COVID-19 pandemic evolves.Read more
The Global Fund's product and delivery outlook shows the overall impact of COVID-19 on health product supply chains for Global Fund grants remains at moderate.Read more
The Global Fund and Gavi, the Vaccine Alliance have published new guidance for countries planning the selection, acquisition and deployment of new logistics management information system (LMIS) software. The guidance identifies off-the-shelf applications and service providers meeting global standards and common requirements for health supply chain LMIS that are appropriate in challenging and resource-constrained environments.Read more